Afinitor and Pancytopenia - a phase IV clinical study of FDA data
Summary:
Pancytopenia is reported as a side effect among people who take Afinitor (everolimus), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Exemestane, and have Paraganglion neoplasm malignant.
The phase IV clinical study analyzes which people have Pancytopenia when taking Afinitor. It is created by eHealthMe based on reports of 41,609 people who have side effects when taking Afinitor from the FDA, and is updated regularly.
What is Afinitor?
Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 41,680 Afinitor users. Check the latest studies of Afinitor.
What is Pancytopenia?
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) is found to be associated with 1,792 drugs and 2,431 conditions by eHealthMe. Check the latest studies of Pancytopenia.
41,609 people reported to have side effects when taking Afinitor.
Among them, 137 people (0.33%) have Pancytopenia.
Among these 137 people:
How long have people been on Afinitor when they have Pancytopenia? *
What is the gender of people who have Pancytopenia when taking Afinitor? *
What is the age of people who have Pancytopenia when taking Afinitor? *
What are other drugs people take besides Afinitor? *
What are other side effects people have besides Pancytopenia? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Afinitor and have Pancytopenia?
- Check whether Pancytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Afinitor:
- Afinitor (41,680 reports)
Pancytopenia treatments and more:
- Pancytopenia (69,290 reports)
How severe was Pancytopenia and when was it recovered:
Expand to all the drugs that have ingredients of everolimus:
- Pancytopenia and drugs with ingredients of everolimus (315 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Afinitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pancytopenia:
- Pancytopenia (1,792 drugs)
Browse all the conditions that are associated with Pancytopenia:
- Pancytopenia (2,431 conditions)
Related publications that referenced our studies
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on everolimus (the active ingredients of Afinitor) and Afinitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Firmagon vs. Tamsulosin Hydrochloride, side effect and effectiveness comparison - 4 seconds ago
- Could Olanzapine cause Chapped Lips? - 12 seconds ago
- Oxycontin vs. Avinza, side effect and effectiveness comparison - 23 seconds ago
- Lovaza vs. Amlodipine Besylate And Atorvastatin Calcium, side effect and effectiveness comparison - 36 seconds ago
- Could Sirolimus cause C-Reactive Protein Increased? - 36 seconds ago
- Could Sumatriptan Succinate cause Alanine Aminotransferase Increased? - 38 seconds ago
- Drug interactions of Clomiphene Citrate and Norvasc - 38 seconds ago
- Hctz vs. Cardura, side effect and effectiveness comparison - 39 seconds ago
- Drug interactions of Lovastatin and Atenolol - 43 seconds ago
- Sinequan vs. Serzone, side effect and effectiveness comparison - 48 seconds ago